Usefulness of N-terminal-pro B-type natriuretic peptide as a heart failure marker in patients undergoing percutaneous left atrial appendage occlusion

Streb, Witold; Mitręga, Katarzyna; Szymała, Magdalena; Podolecki, Tomasz; Kalarus, Zbigniew

doi:10.5603/kp.a2017.0185

Cited by 1 publication

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The evolution of surgical techniques toward preserving the right atrial appendage has led to a reduction in the incidence of postoperative pulmonary edema [45]. Two small studies indicated a slight rise in brain natriuretic peptide levels after transcatheter LAAO (32 patients together) [47,48]. On the other hand, there are several studies demonstrating that LAAO does not lead to any significant changes in natriuretic peptide levels at all [43,[49][50][51][52].…”

Section: Collateral Impact Of Laa Lossmentioning

confidence: 99%

Left atrial appendage occlusion: Percutaneous and surgical approaches in everyday practice

Gofus,

Zacek,

Shahin

et al. 2024

Pol Heart J

View full text Add to dashboard Cite

Prophylactic left atrial appendage occlusion has been suggested as a means of reducing cardioembolism risk in patients with atrial fibrillation. Its clinical benefits have been discussed together with potential endocrine or hemodynamic adverse effects, with conflicting conclusions. We aimed to provide a thorough overview of the current literature and a recommendation for daily clinical decision-making. A comprehensive Medline search through PubMed was conducted to search for relevant articles, which were further filtered using the title and abstract. Sixty-five articles were selected as relevant to the topic. Concomitant left atrial appendage occlusion during cardiac surgery for other reasons is effective in terms of thromboembolism risk reduction in patients with a history of atrial fibrillation and higher CHA 2 DS 2 -VASc scores. Surgical occlusion is safe, and epicardial closure techniques are preferred. Thoracoscopic and transcatheter techniques are also feasible, and the individual treatment choice must be tailored to the patient. The concerns about endocrine imbalance or risk of heart failure after occlusion are not supported by evidence. Current evidence is conflicting with regard to hemodynamic consequences of appendage occlusion.

show abstract

Section: Collateral Impact Of Laa Lossmentioning

confidence: 99%

Left atrial appendage occlusion: Percutaneous and surgical approaches in everyday practice

Gofus,

Zacek,

Shahin

et al. 2024

Pol Heart J

View full text Add to dashboard Cite

show abstract

Usefulness of N-terminal-pro B-type natriuretic peptide as a heart failure marker in patients undergoing percutaneous left atrial appendage occlusion

Abstract: When diagnosing HF in atrial fibrillation patients, the higher cut-off value of NT-proBNP should be used. NT-proBNP remains an appropriate diagnostic marker of HF in patients after LAAO.

Cited by 1 publication

References 18 publications

Left atrial appendage occlusion: Percutaneous and surgical approaches in everyday practice

Left atrial appendage occlusion: Percutaneous and surgical approaches in everyday practice

Contact Info

Product

Resources

About